Lorundrostat lowers blood pressure compared with placebo at 12 weeks
Among patients with uncontrolled hypertension, the investigational drug lorundrostat brought a significant reduction in blood ...
BioSpace15h
FDA Action Alert: Amgen, Aldeyra and Argenx
In the coming two weeks, the FDA is expected to announce three big decisions, including one for a dry eye disease therapy.
Healio4d
FDA recap: First new treatment for stroke in 3 decades, generic rivaroxaban and more
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
Tonix Pharmaceuticals: Potential To Have 'First' New Fibromyalgia Drug In 15 Years
FDA reviews TNX-102 SL for Fibromyalgia by August 2025, with no advisory required. See why we recommend a buy on TNXP stock.
The American Journal of Managed Care6d
FDA Approves First New Class of Oral Antibiotics for Uncomplicated UTIs in Nearly 30 Years
The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...
Tonix Pharmaceuticals: FDA AdCom News Positive, But Making Bull Case Is Problematic
Tonix Pharma (TNXP) has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. See why I'm on the sidelines.